What is Quince Therapeutics, Inc. Common Stock's Market Cap?

Quince Therapeutics, Inc. Common Stock's Market Cap is $30.0M, based on as-reported figures from SEC (XBRL) filings.

What is Quince Therapeutics, Inc. Common Stock's Enterprise Value?

Quince Therapeutics, Inc. Common Stock's Enterprise Value is -$86.0M, based on as-reported figures from SEC (XBRL) filings.

What is Quince Therapeutics, Inc. Common Stock's EV / EBITDA?

Quince Therapeutics, Inc. Common Stock's EV / EBITDA is 0.7×, based on as-reported figures from SEC (XBRL) filings.

What is Quince Therapeutics, Inc. Common Stock's Net Income (TTM)?

Quince Therapeutics, Inc. Common Stock's Net Income (TTM) is -$92.5M, based on as-reported figures from SEC (XBRL) filings.

What is Quince Therapeutics, Inc. Common Stock's EBITDA?

Quince Therapeutics, Inc. Common Stock's EBITDA is -$127.0M, based on as-reported figures from SEC (XBRL) filings.

What is Quince Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Quince Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -90.92, based on as-reported figures from SEC (XBRL) filings.

What is Quince Therapeutics, Inc. Common Stock's Net Debt?

Quince Therapeutics, Inc. Common Stock's Net Debt is -$116.0M, based on as-reported figures from SEC (XBRL) filings.

Quince Therapeutics, Inc. Common Stock (QNCX) Financial Statements

Quince Therapeutics, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00BTK1DS9

XNAS · usd

29.50▼ 1.82 (-5.81%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close31.32

Day's Range29.01 – 31.88

52-Week Range0.08 – 35.41

Volume12.6K

Avg Volume29.7K

Share Statistics

Shares Outstanding

Employees38

ExchangeXNAS

Listed2019-05-09

Share count as of August 7, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Quince Therapeutics, Inc. Common Stock (QNCX)

What is Quince Therapeutics, Inc. Common Stock's Market Cap?: Quince Therapeutics, Inc. Common Stock's Market Cap is $30.0M, based on as-reported figures from SEC (XBRL) filings.
What is Quince Therapeutics, Inc. Common Stock's Enterprise Value?: Quince Therapeutics, Inc. Common Stock's Enterprise Value is -$86.0M, based on as-reported figures from SEC (XBRL) filings.
What is Quince Therapeutics, Inc. Common Stock's EV / EBITDA?: Quince Therapeutics, Inc. Common Stock's EV / EBITDA is 0.7×, based on as-reported figures from SEC (XBRL) filings.
What is Quince Therapeutics, Inc. Common Stock's Net Income (TTM)?: Quince Therapeutics, Inc. Common Stock's Net Income (TTM) is -$92.5M, based on as-reported figures from SEC (XBRL) filings.
What is Quince Therapeutics, Inc. Common Stock's EBITDA?: Quince Therapeutics, Inc. Common Stock's EBITDA is -$127.0M, based on as-reported figures from SEC (XBRL) filings.
What is Quince Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Quince Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -90.92, based on as-reported figures from SEC (XBRL) filings.
What is Quince Therapeutics, Inc. Common Stock's Net Debt?: Quince Therapeutics, Inc. Common Stock's Net Debt is -$116.0M, based on as-reported figures from SEC (XBRL) filings.